trial

Evaluation of the Individual Early Psychoeducation Program for Schizophrenic Disorders in Inpatients

NCTId NCT05329363
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 200 (estimated)
Sponsored by University Hospital, Tours
Primary completion 2026-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
200 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2022-06-17
Primary completion
2026-06
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
PEPITS Programme

Sponsors

University Hospital, ToursLead Sponsor

Sites

11 total
Blois, FranceChinon, FranceDreux, FranceFleury-les-Aubrais, FranceLa Roche-sur-Yon, FranceNeuilly-sur-Marne, FranceRennes, FranceSaint-Maurice, FranceSainte-Gemmes-sur-Loire, FranceSotteville-lès-Rouen, FranceTours, France

Facts & assertions

4 sourced
Enrollment
200
Phase
NA
Primary Completion Date
2026-06
Status
RECRUITING
relationships
The graph out of here
drug
PEPITS Programme
drug
lead_sponsor
University Hospital, Tours
company
indication
Schizophrenia
indication
Schizophrenia
indication